Genesis Healthcare Inc. buy Wells Fargo & Company
Start price
08.08.25
/
50%
€0.38
Target price
08.08.26
€34.30
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Genesis Healthcare Inc. | - | - |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Genesis Healthcare Inc. diskutieren
Gen Digital Inc. (NASDAQ: GEN) had its price target raised by analysts at Wells Fargo & Company from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for GEN provided by MarketBeat